Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00132
|
|||||
Drug Name |
Phosphate
|
|||||
Synonyms |
14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V)
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Constipation [ICD11: ME05.0] | Approved | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
O4P-3
|
|||||
Canonical SMILES |
[O-]P(=O)([O-])[O-]
|
|||||
InChI |
InChI=1S/H3O4P/c1-5(2,3)4/h(H3,1,2,3,4)/p-3
|
|||||
InChIKey |
NBIIXXVUZAFLBC-UHFFFAOYSA-K
|
|||||
CAS Number |
CAS 14265-44-2
|
|||||
Pharmaceutical Properties | Molecular Weight | 94.971 | Topological Polar Surface Area | 86.2 | ||
Heavy Atom Count | 5 | Rotatable Bond Count | 0 | |||
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 4 | |||
XLogP |
-2.3
|
|||||
PubChem CID | ||||||
PubChem SID |
103066731
, 103077071
, 104042950
, 104075345
, 104296651
, 125331104
, 125823182
, 126524047
, 134989311
, 135292823
, 137001640
, 142051012
, 14709385
, 152043015
, 15218698
, 163304750
, 175268694
, 176264609
, 176270178
, 223741247
, 24439414
, 3071
, 53787703
, 56310835
, 56311388
, 57320705
, 7728230
, 7889982
, 79295108
, 8144764
, 8150953
, 840917
, 841057
|
|||||
ChEBI ID |
CHEBI:18367
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | DIC | Transporter Info | Mitochondrial dicarboxylate carrier | Substrate | [2] | |
G3PP | Transporter Info | Glycerol-3-phosphate permease | Substrate | [3] | ||
NPT1 | Transporter Info | Sodium-dependent phosphate transport protein 1 | Substrate | [4] | ||
NPT4 | Transporter Info | Sodium-dependent phosphate transport protein 4 | Substrate | [5] | ||
PHC | Transporter Info | Phosphate carrier protein | Substrate | [6] | ||
PIT1 | Transporter Info | Sodium-dependent phosphate transporter 1 | Substrate | [7] | ||
PIT2 | Transporter Info | Sodium-dependent phosphate transporter 2 | Substrate | [7] | ||
SCAMC1 | Transporter Info | Calcium-binding mitochondrial carrier protein SCaMC-1 | Substrate | [8] | ||
SCAMC2 | Transporter Info | Calcium-binding mitochondrial carrier protein SCaMC-2 | Substrate | [9] | ||
SCAMC3 | Transporter Info | Calcium-binding mitochondrial carrier protein SCaMC-3 | Substrate | [10] | ||
SLC17A4 | Transporter Info | Probable small intestine urate exporter | Substrate | [11] | ||
VGLUT1 | Transporter Info | Vesicular glutamate transporter 1 | Substrate | [12] | ||
VGLUT2 | Transporter Info | Vesicular glutamate transporter 2 | Substrate | [4] | ||
References | ||||||
1 | Phosphate was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | SLC25A10 biallelic mutations in intractable epileptic encephalopathy with complex I deficiency. Hum Mol Genet. 2018 Feb 1;27(3):499-504. | |||||
3 | SLC37A1 and SLC37A2 are phosphate-linked, glucose-6-phosphate antiporters. PLoS One. 2011;6(9):e23157. | |||||
4 | Type 1 sodium-dependent phosphate transporter (SLC17A1 Protein) is a Cl(-)-dependent urate exporter. J Biol Chem. 2010 Aug 20;285(34):26107-13. | |||||
5 | Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate. J Biol Chem. 2010 Nov 5;285(45):35123-32. | |||||
6 | The mammalian phosphate carrier SLC25A3 is a mitochondrial copper transporter required for cytochrome c oxidase biogenesis. J Biol Chem. 2018 Feb 9;293(6):1887-1896. | |||||
7 | Phosphate transporters and their function. Annu Rev Physiol. 2013;75:535-50. | |||||
8 | De Novo Mutations in SLC25A24 Cause a Disorder Characterized by Early Aging, Bone Dysplasia, Characteristic Face, and Early Demise. Am J Hum Genet. 2017 Nov 2;101(5):844-855. | |||||
9 | Ketogenic diet induces expression of the muscle circadian gene Slc25a25 via neural pathway that might be involved in muscle thermogenesis. Sci Rep. 2017 Jun 6;7(1):2885. | |||||
10 | Cellular expression and alternative splicing of SLC25A23, a member of the mitochondrial Ca2+-dependent solute carrier gene family. Gene. 2005 Jan 31;345(2):173-82. | |||||
11 | A Na+-phosphate cotransporter homologue (SLC17A4 protein) is an intestinal organic anion exporter. Am J Physiol Cell Physiol. 2012 Jun 1;302(11):C1652-60. | |||||
12 | SLC17: a functionally diverse family of organic anion transporters. Mol Aspects Med. 2013 Apr-Jun;34(2-3):350-9. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.